Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Cash Flow Statement
Cash Flow Statement
Anebulo Pharmaceuticals Inc
Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||
Net Income |
(32)
|
(32)
|
(34)
|
(7)
|
(8)
|
(11)
|
(12)
|
(12)
|
(12)
|
(10)
|
|
Other Non-Cash Items |
27
|
27
|
27
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
(1)
|
(1)
|
(0)
|
1
|
1
|
2
|
2
|
1
|
0
|
(0)
|
|
Cash from Operating Activities |
(6)
N/A
|
(6)
-12%
|
(7)
-4%
|
(5)
+17%
|
(7)
-23%
|
(8)
-21%
|
(9)
-9%
|
(10)
-10%
|
(10)
-7%
|
(10)
+8%
|
|
Financing Cash Flow | |||||||||||
Net Issuance of Common Stock |
0
|
0
|
21
|
0
|
7
|
7
|
7
|
7
|
0
|
0
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
|
Cash from Financing Activities |
0
N/A
|
0
N/A
|
20
N/A
|
0
N/A
|
7
N/A
|
6
-4%
|
6
N/A
|
6
-1%
|
(0)
N/A
|
(0)
+59%
|
|
Change in Cash | |||||||||||
Net Change in Cash |
16
N/A
|
16
-4%
|
13
-15%
|
(5)
N/A
|
0
N/A
|
(2)
N/A
|
(2)
-44%
|
(3)
-39%
|
(11)
-224%
|
(10)
+9%
|
|
Free Cash Flow | |||||||||||
Free Cash Flow |
(6)
N/A
|
(6)
-12%
|
(7)
-4%
|
(5)
+17%
|
(7)
-23%
|
(8)
-21%
|
(9)
-9%
|
(10)
-10%
|
(10)
-7%
|
(10)
+8%
|